2016年5月
Programmed Cell Death Ligand 1 Expression in Canine Cancer
IN VIVO
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 30
- 号
- 3
- 開始ページ
- 195
- 終了ページ
- 204
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- 出版者・発行元
- INT INST ANTICANCER RESEARCH
Background: Antibody therapy targeting programmed cell death-1 (PD-1) and programmed cell death-ligand 1 (PD-L1) is a promising therapy in human cancer, but only limited information on PD-L1 expression in canine tumors is available. Materials and Methods: PD-L1 expression was examined in 31 canine tumor cell lines of various origins by flow cytometry and western blotting, and in canine tumor and normal tissue specimens by immunohistochemistry. Results: PD-L1 was only expressed on the cell surface of a small number of cell lines but was found expressed within the cells of almost all cell lines. Immunohistochemistry revealed that PD-L1 is frequently expressed in malignant melanoma, mammary gland tumor, mast cell tumor and lymphoma, but less frequently in softtissue sarcoma and hemangiosarcoma. PD-L1 was also expressed in some of the cells of normal canine tissue specimens. Conclusion: Canine tumors with PD-L1 expression that were identified in this study are potential candidates for antiPD-1 and antiPD-L1 therapy.
- リンク情報
- ID情報
-
- ISSN : 0258-851X
- eISSN : 1791-7549
- Web of Science ID : WOS:000375327800005